Alexo Therapeutics Ltd — Form D
Alexo Therapeutics Ltd of DUBLIN 2, L2, a company, filed a Form D exempt-offering notice with the SEC on 2015-05-21. The offering totals $36.0M, of which $18.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-05-21
- Form: D
- Accession: 0001642930-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $36.0M
- Amount sold: $18.0M
- Remaining: $18.0M
- Minimum investment: $38K
- Investors: 14
- Date of first sale: 2015-05-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-240360
Issuer
- Name: Alexo Therapeutics Ltd
- CIK: 0001642930
- Entity type: Other
- Jurisdiction: IRELAND
- Incorporated: 2015
- Address: C/O BRADWELL LIMITED, DUBLIN 2, L2, 000000
- Phone: 35-3-1-618-000
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Corey Goodman | Director | Cambridge, MA |
| Jason Lettman | Director | Minneapolis, MN |
| Jaume Pons | Director | Burlingame, CA |
| n/a Bradwell Limited | Executive Officer | Dublin 2, L2 |
More